CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax of -$2.22 million for the 9-month period ending 2022-09-24, per its 10-Q filed 2022-11-02.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax · last filed 2022-11-02
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reclassification from accumulated other comprehensive income, current period, before tax for the quarter ending 2022-09-24 was -$731.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reclassification from accumulated other comprehensive income, current period, before tax for the quarter ending 2022-06-25 was -$741.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reclassification from accumulated other comprehensive income, current period, before tax for the quarter ending 2022-03-26 was -$746.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reclassification from accumulated other comprehensive income, current period, before tax for the quarter ending 2021-12-25 was $1.29M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reclassification from accumulated other comprehensive income, current period, before tax for fiscal 2021 was -$1.68M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reclassification from accumulated other comprehensive income, current period, before tax for fiscal 2020 was -$17.86M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reclassification from accumulated other comprehensive income, current period, before tax for fiscal 2019 was -$1.77M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reclassification from accumulated other comprehensive income, current period, before tax for fiscal 2018 was -$2.48M.
| Period end | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 3 month | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 6 month | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 9 month | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 12 month |
|---|---|---|---|---|
| 2022-09-24 | -$731.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$1.47M derived: sum of 2 quarters · filed 2022-11-02 | -$2.22M 10-Q · filed 2022-11-02 | -$924.00K derived: sum of 4 quarters · filed 2022-11-02 |
| 2022-06-25 | -$741.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$1.49M 10-Q · filed 2022-08-03 | -$193.00K derived: sum of 3 quarters · filed 2022-08-03 | -$1.18M derived: sum of 4 quarters · filed 2022-08-03 |
| 2022-03-26 | -$746.00K 10-Q · filed 2022-05-04 | $548.00K derived: sum of 2 quarters · filed 2022-05-04 | -$443.00K derived: sum of 3 quarters · filed 2022-05-04 | -$1.44M derived: sum of 4 quarters · filed 2022-05-04 |
| 2021-12-25 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $303.00K derived: sum of 2 quarters · filed 2022-02-16 | -$690.00K derived: sum of 3 quarters · filed 2022-02-16 | -$1.68M 10-K · filed 2022-02-16 |
| 2021-09-25 | -$991.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$1.98M derived: sum of 2 quarters · filed 2021-11-03 | -$2.97M 10-Q · filed 2021-11-03 | -$16.68M derived: sum of 4 quarters · filed 2022-02-16 |
| 2021-06-26 | -$993.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$1.98M 10-Q · filed 2021-08-04 | -$15.69M derived: sum of 3 quarters · filed 2022-02-16 | -$17.10M derived: sum of 4 quarters · filed 2022-02-16 |
| 2021-03-27 | -$988.00K 10-Q · filed 2021-05-04 | -$14.70M derived: sum of 2 quarters · filed 2022-02-16 | -$16.11M derived: sum of 3 quarters · filed 2022-02-16 | -$17.48M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-12-26 | -$13.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$15.12M derived: sum of 2 quarters · filed 2022-02-16 | -$16.49M derived: sum of 3 quarters · filed 2022-02-16 | -$17.86M 10-K · filed 2022-02-16 |
| 2020-09-26 | -$1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$2.78M derived: sum of 2 quarters · filed 2020-10-29 | -$4.15M 10-Q · filed 2020-10-29 | -$4.81M derived: sum of 4 quarters · filed 2021-02-17 |
| 2020-06-27 | -$1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$2.74M 10-Q · filed 2020-08-05 | -$3.40M derived: sum of 3 quarters · filed 2021-02-17 | -$3.76M derived: sum of 4 quarters · filed 2021-02-17 |
| 2020-03-28 | -$1.37M 10-Q · filed 2020-05-07 | -$2.03M derived: sum of 2 quarters · filed 2021-02-17 | -$2.40M derived: sum of 3 quarters · filed 2021-02-17 | -$2.77M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-12-28 | -$659.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | -$1.02M derived: sum of 2 quarters · filed 2021-02-17 | -$1.40M derived: sum of 3 quarters · filed 2021-02-17 | -$1.77M 10-K · filed 2021-02-17 |
| 2019-09-28 | -$365.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$739.00K derived: sum of 2 quarters · filed 2019-11-06 | -$1.11M 10-Q · filed 2019-11-06 | -$1.73M derived: sum of 4 quarters · filed 2020-02-11 |
| 2019-06-29 | -$374.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | -$748.00K 10-Q · filed 2019-07-31 | -$1.36M derived: sum of 3 quarters · filed 2020-02-11 | -$1.98M derived: sum of 4 quarters · filed 2020-02-11 |
| 2019-03-30 | -$374.00K 10-Q · filed 2019-05-07 | -$987.00K derived: sum of 2 quarters · filed 2020-02-11 | -$1.60M derived: sum of 3 quarters · filed 2020-02-11 | -$2.39M derived: sum of 4 quarters · filed 2020-02-11 |
| 2018-12-29 | -$613.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11 | -$1.23M derived: sum of 2 quarters · filed 2020-02-11 | -$2.02M derived: sum of 3 quarters · filed 2020-02-11 | -$2.48M 10-K · filed 2020-02-11 |
| 2018-09-29 | -$615.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$1.41M derived: sum of 2 quarters · filed 2018-11-07 | -$1.86M 10-Q · filed 2018-11-07 | -$2.57M derived: sum of 4 quarters · filed 2019-02-13 |
| 2018-06-30 | -$790.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$1.25M 10-Q · filed 2018-08-08 | -$1.96M derived: sum of 3 quarters · filed 2019-02-13 | -$2.84M derived: sum of 4 quarters · filed 2019-02-13 |
| 2018-03-31 | -$459.00K 10-Q · filed 2018-05-10 | -$1.17M derived: sum of 2 quarters · filed 2019-02-13 | -$2.05M derived: sum of 3 quarters · filed 2019-02-13 | -$2.95M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-12-30 | -$706.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | -$1.59M derived: sum of 2 quarters · filed 2019-02-13 | -$2.49M derived: sum of 3 quarters · filed 2019-02-13 | -$3.34M 10-K · filed 2019-02-13 |
| 2017-09-30 | -$883.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$1.78M derived: sum of 2 quarters · filed 2017-11-09 | -$2.64M 10-Q · filed 2017-11-09 | -$2.39M derived: sum of 4 quarters · filed 2018-02-13 |
| 2017-07-01 | -$901.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$1.75M 10-Q · filed 2017-08-09 | -$1.50M derived: sum of 3 quarters · filed 2018-02-13 | |
| 2017-04-01 | -$854.00K 10-Q · filed 2017-05-10 | -$604.00K derived: sum of 2 quarters · filed 2018-02-13 | ||
| 2016-12-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$1.71M 10-K · filed 2018-02-13 | ||
| 2016-09-24 | -$1.96M 10-Q · filed 2016-11-02 | |||
| 2015-12-26 | -$432.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$1.13M derived: sum of 2 quarters · filed 2017-02-14 | -$1.89M derived: sum of 3 quarters · filed 2017-02-14 | -$276.00K 10-K · filed 2017-02-14 |
| 2015-09-26 | -$695.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$1.46M derived: sum of 2 quarters · filed 2015-11-04 | $156.00K 10-Q · filed 2015-11-04 | |
| 2015-06-27 | -$761.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $851.00K 10-Q · filed 2015-07-30 | ||
| 2015-03-28 | $1.61M 10-Q · filed 2015-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |